A Safety and Efficacy Trial of Recombinant Human Activated Protein C in Both Early-Onset Pre-Eclampsia and Severe Postpartum Pre-Eclampsia.
Phase of Trial: Phase II
Latest Information Update: 03 Feb 2011
At a glance
- Drugs Drotrecogin alfa (Primary)
- Indications Preeclampsia
- Focus Therapeutic Use
- 12 Aug 2008 Planned end date changed from 1 Dec 2006 to 1 Dec 2010 as reported by ClinicalTrials.gov.
- 06 Nov 2006 New trial record.